YOLFTbeta
BPH Global Ltd

BPH Global Ltd

BP8 · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.013AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.013
Open0.013
Day Range0.013 – 0.013
52-Week Range0.01 – 0.03
Volume1.02M
Market Cap3.06M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.01
Dividend Yield0.00%
Beta0.53
50-Day Avg0.0153
200-Day Avg0.0179

About

Ocean Sciences Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company's products include raw bird's nest and processed bird's nest products, and Caulerpa Lentillifera, sea grapes, and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. Ocean Sciences Ltd was formerly known as BPH Global Ltd and changed its name to Ocean Sciences Ltd in September 2026. The company was incorporated in 1984 and is based in Melbourne, Australia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Francesco Cannavo
  • Employees0
  • Headquarters365 Little Collins Street, Melbourne, VIC, Australia, 3000, Australia
  • Websitehttps://bphglobal.com

Leadership

  • Mr. Francesco CannavoInterim Executive Chairman
  • Mr. Matthew Robert LeonardMD & Executive Director
  • Mr. Chow-Yee KohChief Financial Officer · b. 1976
  • Ms. Ifat MazouzChief Scientific Officer
  • Mr. Justyn Peter Stedwell B.Com.Company Secretary · b. 1981

Financials

Income Statement

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-819.00K12.72M9.62M127.19M312.82M477.77M769.14M1.01B6.83K74.75K31.62K290.68K1.56M730.36K8.50M14.35M339109.97K352.38K3.44M
Growth (%)--+1452.87%-24.36%+1222.20%+145.96%+52.73%+60.99%+31.76%-100.00%+994.48%-57.70%+819.32%+437.16%-53.23%+1063.19%+68.94%-100.00%+32338.05%+220.44%+877.51%
Cost of Revenue--7.16M5.70M119.70M303.69M452.80M744.72M967.29M71.18K86.76K25.97K224.77K1.45M593.33K6.95M12.07M-91.69K1.03M4.33M
Gross Profit--5.56M3.92M7.49M9.14M24.97M24.42M46.14M-64.35K-12.01K5.65K65.91K114.65K137.03K1.54M2.29M33918.27K-678.01K-890.49K
Gross Margin--43.71%40.73%5.89%2.92%5.23%3.18%4.55%-942.17%-16.06%17.87%22.67%7.34%18.76%18.18%15.93%100.00%16.61%-192.41%-25.85%
Operating Expense--2.88M3.07M7.06M14.65M23.78M36.46M49.45M944.83K995.47K1.21M1.98M807.91K1.49M3.95M5.24M2.51M1.77M777.83K882.94K
Operating Income--2.68M846.35K430.09K-5.51M1.19M-12.04M-3.31M-1.01M-1.01M-1.21M-1.91M-693.26K-1.35M-2.41M-2.95M-2.51M-1.75M-1.46M-1.77M
Operating Margin--21.09%8.80%0.34%-1.76%0.25%-1.56%-0.33%-14775.67%-1347.74%-3817.72%-657.24%-44.40%-184.71%-28.33%-20.57%-740745.13%-1595.85%-413.15%-51.49%
EBITDA--287.00K635.00K1.14M3.90M10.20M12.99M5.88M28.28M75.17M-35.49M-725.25K-3.25M-674.94K-1.33M-2.41M-2.49M-3.52M-1.76M-1.45M-1.76M
EBITDA Margin--35.04%4.99%11.84%3.06%3.26%2.72%0.76%2.79%1100587.57%-47482.73%-2293.73%-1118.39%-43.23%-182.05%-28.39%-17.38%-1037532.74%-1597.94%-412.42%-51.07%
Net Income-4.09K273.54K-97.00K256.08K1.08M2.33M-2.28M-14.06M-2.85M75.04M-35.62M-3.63M-3.35M-3.54M-1.58M-3.13M-3.54M-4.32M-2.27M-1.49M-1.79M
Net Income Margin-33.40%-0.76%2.66%0.85%0.74%-0.48%-1.83%-0.28%1098700.44%-47648.07%-11483.85%-1153.64%-226.59%-216.32%-36.88%-24.65%-1273736.87%-2065.73%-421.87%-51.91%
R&D-------2.05M4.45M------270.51K279.32K49.92K-70.57K49.18K
R&D as % of Total Revenue-------0.27%0.44%------3.18%1.95%14726.25%-20.03%1.43%
Interest Expense000000000002.95K00024.12K62.64K-20.41K33.74K88.65K
Interest Expense % of Total Revenue-0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%9.33%0.00%0.00%0.00%0.28%0.44%-18.56%9.57%2.57%

Balance Sheet

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets12.04M13.11M17.66M17.64M37.81M80.48M138.01M205.93M280.75M21.11K3.58M4.88M2.63M1.58M2.43M1.01M9.23M7.62M2.10M691.84K541.00K1.38M
Total Liabilities6.41M7.92M6.37M6.09M25.18M62.54M76.86M138.44M212.78M76.27M3.43M726.55K508.69K380.97K349.94K252.54K2.75M2.90M1.19M1.97M2.01M2.26M
Total Equity5.63M5.19M11.29M11.55M12.64M17.95M21.48M9.29M25.25M-76.25M149.84K4.15M2.12M1.20M1.69M462.22K5.55M3.04M530.13K-966.82K-1.45M-868.82K
Cash1.94M276.81K62.00K65.88K12.87M10.16M13.13M6.88M7.20M-3.55M272.90K1.04M1.09M1.90M866.83K5.26M624.96K510.22K133.62K152.74K259.88K
Total Debt5.77M5.13M2.47M2.28M2.97M17.65M28.06M44.24M82.41M-3.26M-202.99K---970.49K1.25M-508.64K-555.74K
Net Debt3.82M4.86M2.40M2.21M-9.90M7.48M14.93M37.37M75.21M--291.67K-272.90K-839.57K-1.09M-1.90M-866.83K-4.28M626.80K-510.22K375.02K-152.74K295.86K

Cash Flow

Currency: AUD1999-06-302000-06-302001-06-302002-06-302003-06-302004-06-302005-06-302006-06-302007-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--1.03M-13.26M8.06M-25.96M-5.72M-612.90K-964.59K-368.03K-1.56M-888.26K-1.28M-1.35M-2.62M-1.34M--929.81K-2.14M
Investing Cash Flow---------31.56M-2.58M-2.58M-137.63K-137.63K-202.36K208.15K-418.04K-914.21K6.29K185.33K-2.37K-8.38K
Financing Cash Flow-1.79M-870.00K171.02K264.99K16.46M44.96M6.34M37.60M4.17M267.66K1.15M1.77M1.85M208.00K6.25M281.27K1.38M697.04K962.99K2.44M
Capital Expenditure868.23K0177.00K105.98K11.78K26.12M26.77M33.65M34.17M168.73K168.73K137.63K137.63K431.02K431.02K431.02K914.21K58.79K22.37K8.38K
Free Cash Flow-838.24K-600.28K853.00K-220.63K13.24M-18.05M-42.93M-7.69M-39.89M-619.72K-1.13M-368.03K-1.70M-888.26K-1.28M-1.78M-4.93M-1.49M-1.26M-932.18K-2.14M
Dividends Paid-----529.64K837.00K--------------
FCF to OCF--82.82%-99.91%-223.94%--29.61%697.80%101.11%117.49%100.00%108.82%100.00%100.00%132.05%188.32%110.98%-100.25%100.39%
Dividend Paid to FCF------2.93%-1.95%--------------

Earnings

Report DateFeb 29, 2016Sep 30, 2016Oct 1, 2016Feb 28, 2017Sep 29, 2017Feb 28, 2018Aug 31, 2018Feb 28, 2019Aug 30, 2019Feb 28, 2020Aug 31, 2020Feb 26, 2021Aug 30, 2021Feb 28, 2022Sep 30, 2022Mar 1, 2023Mar 6, 2025Aug 29, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.00-0.09-0.090.00-0.010.000.000.000.000.000.000.000.000.000.000.000.000.00
Surprise------------------
Timing--------------After-hoursPre-market--

Key Statistics & Ratios

Market Cap3.06M
Enterprise Value3.59M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.89
Price / Book2.63
EPS-0.01
Book Value-0.004
Revenue (TTM)3.44M
Gross Profit (TTM)63.97K
EBITDA-1.76M
Profit Margin-51.91%
Operating Margin-37.62%
Return on Equity-745.91%
Return on Assets-115.63%
Shares Outstanding235.35M
Shares Float131.07M
Beta0.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20051×
0.01Jan 10, 2005
20041×
0.01Feb 23, 2004

Stock Splits

  • Sep 15, 20261:10
  • May 28, 20241:5
  • Jul 1, 20151:2
  • Sep 8, 20141:22